Variation in genes encoding costimulatory molecules expressed on lymphocytes has been expected to contribute to the genetic component of inflammatory disease, but only the gene encoding the inhibitory protein, CTLA-4, seems consistently to confer disease susceptibility. Studies in murine models implicate the inhibitory product of the pd1 gene, programmed death-1, in the maintenance of peripheral tolerance to self-antigens. We identify 22 single-nucleotide polymorphisms (SNPs) in the equivalent human gene, PDCD1, a number of which show significant associations with the specific immunoglobulin E response to grass allergens in atopic individuals. Stepwise analyses indicate that four of the disease-associated SNPs have independent effects. The two most common haplotypes show positive and negative associations but rarer haplotypes are also likely to be of influence. In a case-control study, multiple regression analysis of genotypic data implies that PDCD1 also confers susceptibility to rheumatoid arthritis. Along with work linking PDCD1 with susceptibility to another autoimmune condition, systemic lupus erythematosus, our data identify PDCD1 as a second immunomodulatory gene with pleiotropic effects in human disease. Genes encoding negative regulators may generally confer a significant fraction of the genetic risk associated with inherited inflammatory disorders.
Introduction
Costimulatory receptors profoundly affect the course of immune responses. Signals resulting from the engagement of CD28 and CTLA-4, expressed on T cells, by their ligands, B7-1 and B7-2 on antigen presenting cells, amplify the weak transcriptional changes elicited by T-cell receptor engagement and terminate on-going responses, respectively.
1,2 Chromosome 2q33-34, which harbours the CD28 and CTLA4 genes, has been implicated in a number of inherited autoimmune and inflammatory diseases by several genome-wide scans (reviewed in Kristiansen et al 3 ) . Accordingly, CD28 and CTLA4 have received considerable attention in candidate gene studies of immune pathology. Two polymorphisms have been identified in CD28 that exhibit poorly reproduced association with systemic lupus erythematosus (SLE) and multiple sclerosis (MS). 4, 5 In contrast, numerous studies link polymorphism in CTLA4 to susceptibility to Type I diabetes mellitus, Grave's disease, Hashimoto's thyroiditis, Addison's disease, SLE, MS and rheumatoid arthritis (RA), although some of these associations are controversial. 6 The general understanding of costimulation was transformed by the discovery of costimulatory molecules, including programmed death (PD)-1, ICOS and BTLA, which modulate the responses of previously activated T-and B cells by binding ligands expressed in secondary lymphoid organs or parenchymal (peripheral) tissues.
7-10 PD-1 is expressed on a subset of thymocytes and up regulated on activated T, B and myeloid cells (reviewed in Okazaki et al 8 and Carreno and Collins 11 ). The PD-1 ligands, B7-H1 and B7-DC, are more widely expressed than those of CD28, CTLA-4 or ICOS. B7-H1 and B7-DC are expressed on activated but not resting B cells, monocytes and dendritic cells in response to pro-inflammatory agents, and B7-DC but not B7-H1 is expressed in a variety of peripheral tissues, including heart, pancreas, lung and liver. PD-1 belongs to the immunoglobulin superfamily and has a cytoplasmic domain containing two tyrosine residues located within immunoreceptor tyrosine-based inhibitory and switch motifs (ITIM and ITSM), suggesting that PD-1 is predominantly inhibitory. Consistent with this proposal, pd1-deficient mice develop a lupus-like glomerulonephritis or autoimmune dilated cardiomyopathy depending on the strain of mice in which the gene is deleted. 12, 13 The PD-1 gene (PDCD1) is located on human chromosome 2q37.3, telomeric to the CD28/CTLA4/ICOS gene cluster. In a study of Nordic families, four SNPs were identified in PDCD1, one of which was found to contribute to the development of SLE. 14 Analysis of the contribution of costimulatory molecules to atopic disease was initially prompted by several genome-wide screens for asthma and its associated traits, which revealed linkage to the chromosomal region 2q33 containing CD28 and CTLA4. [15] [16] [17] [18] In contrast to data obtained for autoimmune diseases, however, candidate gene studies of CTLA4 in the context of asthma and its related phenotypes gave mixed results. Heinzmann et al 19 found no associations with asthma or atopy for two single-nucleotide polymorphisms (SNPs) identified in the CTLA4 gene. The same SNPs, however, were linked to elevated total serum IgE levels in both Dutch and Japanese asthmatics 20, 21 and with either asthma severity or airway hyper-responsiveness in Korean patients. 22 The observations that PD-1 is likely to be involved in maintaining peripheral tolerance, and that its gene is adjacent to the 2q33 region, made PDCD1 a strong candidate susceptibility gene for asthma and its related phenotypes. We have undertaken a systematic search for SNPs in this gene and tested these for association to measures of atopy in two panels of families. The findings that CTLA4 is pleiotropic and that PDCD1 may be implicated in SLE 14 prompted us to analyse PDCD1 in patients with RA. Our results suggest that genes encoding negative regulators of immune responses, such as PDCD1 and CTLA4, may confer a significant fraction of the genetic risk associated with inherited inflammatory disease.
Results

SNP identification
A systematic search of the PDCD1 gene identified 22 SNPs. A total of 18 SNPs were novel and four had been identified previously 14 ( Figure 1 ). Previously identified SNPs included the two intron 4 SNPs, PD-1 þ 7078 and PD-1 þ 7431 (PD-1.3 and PD-1.4 according to the nomenclature of Prokunina et al), the synonymous exon 5 SNP PD-1 þ 7717 (PD-1.5) and the 3 0 UTR SNP PD-1 þ 8669 (PD-1.6). Three rare SNPs reported by Prokunina et al, PD-1.1, PD-1.2 and PD-1.9, were not found in our population. The 18 novel SNPs were all located within introns. For each SNP, the base change, its position relative to the first base of the start codon, the sequence surrounding the SNP and the minor allele frequency in the Panel A founders are given in Table 1 . The allele frequencies were not different in the Panel B founders or the individuals used for SNP detection.
Associations of PDCD1 SNPs with atopic phenotypes
The SNPs were initially genotyped in subjects (n ¼ 364) from Busselton in Western Australia. The individuals were predominantly of British ancestry, with approximately 10% owing their origins to southern Europe. The eighty families surveyed included a total of 203 offspring. The mean age of the children was 12.671.3 (s.e.) years, their geometric mean IgE was 55.771.1 kU/l and their mean RAST Index (RASTI) was 2.170.20 K a U/l. In all, 52% of the children were atopic and 12% were asthmatic. For replication purposes, a second panel (Panel B) consisting of 410 white British individuals was used. The families studied included 293 offspring with a mean age of 16.470.9 (s.e.) years, their geometric mean IgE was 101.370.12 kU/l while their mean RASTI was 1.970.14 K a U/l. A total of 69% were atopic and 56% were asthmatic, reflecting their ascertainment through an asthmatic or atopic proband.
All 22 PDCD1 SNPs were genotyped in Panel A subjects. Panel B subjects were genotyped for 13 of the SNPs. We detected a 3% genotyping error using the Merlin programme. The PD-1 þ 2375 and PD-1 þ 2973 SNPs were not in Hardy-Weinberg equilibrium but were retained in the analyses as they formed consistent inheritance in haplotypes.
Weak associations were seen for the categorical traits of atopy and asthma for a number of SNPs (data not shown), with the most significant result being seen for PD-1 þ 3928 and atopy (P ¼ 0.02, Panel A subjects). However, these associations did not remain significant after correction for multiple comparisons.
For the quantitative traits examined, multiple SNPs showed association with antigen-specific IgE (measured using the RASTI; Table 2 ). Only three SNPs showed association with the total serum IgE levels, and the associations seen were considerably weaker than those seen for the RASTI (PD-1 þ 1353, PD-1 þ 2349, PD-1 þ 7717, P-values 0.04, 0.009 and 0.03). Inclusion of the RASTI as a covariate abolished all associations to the total serum IgE, whereas use of the total serum IgE did not abolish associations to the RASTI. This indicated that the primary association was with antigen-specific IgE. Since the RASTI is a summation of the specific IgE to house dust mite (HDM) and grass, associations were examined to IgE to the individual antigens ( Table 2 ). These results suggested that the primary association was to grass pollen-specific IgE levels.
Replication was sought using Panel B subjects and PD-1 SNPs that had shown association in Panel A subjects or SNPs typed in the previous study of PD-1 and SLE. 14 For each SNP marker the base change is given, along with the flanking sequence surrounding the SNP, the position of the SNP marker relative to the start codon (accession number AF363458) and the minor allele frequency. Indicates SNP previously reported in the literature.
14 Linkage disequilibrium between markers was incomplete (Figure 2 ), suggesting that association to the region was unlikely to be attributable to a single haplotype. A stepwise analysis was therefore undertaken to determine whether the multiple associations represented independent effects. In this procedure, the most-associated SNP was included as a covariate in the QTDT analysis for RASTI and the association was re-tested in a stepwise fashion until no significant associations (Po0.01) remained. This analysis indicated that PD-1 þ 2349 (w 2 ¼ 11.39,
PDCD1 haplotypes: associations with atopic phenotypes Haplotype construction identified 12 founder haplotypes from the four SNPs. The most common haplotype, that is, PD-1 þ 2349*2/PD-1 þ 4417*2/PD-1 þ 7717*2/PD-1 þ 9252*2 (haplotype PD-1A *2*2*2*2) was negatively associated with the RASTI (P ¼ 0.03; 1.3% of the variance). The second most common haplotype, that is, PD-1 þ 2349*1/PD-1 þ 4417*1/PD-1 þ 7717*1/PD-1 þ 9252*1 (haplotype PD-1B *1*1*1*1) was positively associated with the RASTI (P ¼ 0.005; 2.4% of the variance). These two haplotypes are mirror images of one another. Similar results were seen for PSTI and RAST Grass (data not shown). Haplotypes PD-1A and PD-1B only accounted for 67.4% of the total number of haplotypes. The stepwise analyses suggest that rarer haplotypes also influence atopic phenotypes, but their numbers are too small to detect associations in our samples.
We derived haplotypes using the four SNPs (PD-1 þ 7078, PD-1 þ 7431, PD-1 þ 7717, PD-1 þ 8669) used in a previous study of SLE 14 (Table 3) . Seven haplotypes with a frequency greater than 1% were seen. These showed similar frequencies to those observed in the study of SLE patients, once it was recognised that the coding of alleles within the haplotypes reported in their original paper 14 was inaccurate (M Alarcon-Riquelme, personal communication).
PDCD1 SNPs and haplotypes associated with rheumatoid arthritis PDCD1 SNPs were selected for genotyping in a casecontrol study of RA patients. The subset of SNPs consisted of those identified in both the present study and by Prokunina et al, as well as the four SNPs exhibiting independent effects in the context of atopy. All genotyping was performed by restriction digestion assays of SNP-specific PCR products. In total, 216 RA cases (all fulfilling the 1987 American College of Rheumatology (ACR) criteria for RA 23 ) and 376 ageand sex-matched controls were genotyped. Logistic regression analysis revealed two SNPs to have independent significant effects (Table 4) . A weak association was seen for PD-1 þ 7717 (P ¼ 0.01), whereas the association with PD-1 þ 5640 was significantly stronger (P ¼ 0.005). Both of these SNPs had shown significant associations to specific IgE levels in the Panel A families (Table 2) .
Haplotypes were derived using the four PDCD1 SNPs common to this study and that of Prokunina et al 
Discussion
We undertook the identification of all the common polymorphisms within the PDCD1 gene, including the promoter, and have identified 22 SNPs including four that have been reported previously. 14 The analysis has revealed significant associations between a number of SNPs spanning the gene and measures of atopy, including the RAST index and specific serum IgE titres against grass pollen. Linkage disequilibrium between markers was incomplete, and stepwise analysis revealed four markers having independent effects. The results were replicated for a second set of subjects, indicating that PDCD1 is a genetic factor modulating specific IgE responses. We also found significant associations between PDCD1 and RA in an independent case-control study. Along with the study of SLE patients by Prokunina et al, 14 our results indicate that PDCD1 polymorphism plays a significant role in peripheral immune responses in humans.
We observed only weak associations to asthma, but the numbers of asthmatics in the panels were not sufficient to consistently detect moderate effects. Dissection of the relationship between genotype, quantitative traits underlying asthma and asthma itself will rely on larger population surveys.
We identified two common PDCD1 haplotypes, one causal and one protective, which are mirror images of one another. Additional, rarer haplotypes may also be important but their frequencies were too small for us to detect associations in our data sets. In their study of SLE in Nordic families, Prokunina et al 14 identified a total of five haplotypes for the seven PDCD1 SNPs they genotyped. Comparisons with these haplotypes were made possible by constructing haplotypes using the four SNPs common to both studies. We found that the haplotype frequencies were similar to those analysed by Prokunina et al.
Allergic or atopic disorders, based on immunological similarities between autoimmunity and allergy, have generally been thought to be common in patients with SLE. Studies of cytokine expression in the past suggested a plausible link between SLE and allergy as Th2 cytokines (IL-4, IL-5, IL-6 and IL-10) are prevalent in both conditions. 24 However, not all the studies are consistent and the most recent work suggests that, for SLE patients for which there is a statistically significant allergic family history, proportionally fewer suffer from allergic disease, suggesting that there is a factor that ameliorates allergic disease in SLE patients. 25 Exogenous and endogenous antigens are recognised by CD4 þ or CD8 þ T cells, respectively. In SLE, a decrease in the CD4/CD8 ratio can be observed that is due to an increase in the numbers of CD8 þ cells, [26] [27] [28] whereas for atopic dermatitis an increase in the CD4/CD8 ratio results from the expansion of CD4 þ cells. 29 It seems likely that the coexistence of two diseases dependent on differences in the CD4/CD8 ratio will be rare because the presence of one type of disease reduces the likelihood that the other develops. 25 An important property of the contribution of PD-1 to the asthma phenotype is that it contributes to the specificity of allergic responses, that is, to grass allergens in particular, rather than simply to the overall degree of IgE production, identifying PDCD1 as an immune response gene. PD-1 is generally believed to be an inhibitor of peripheral immune responses, although this issue is not entirely settled. Ligation of PD-1 results in the phosphorylation of its cytoplasmic domain and recruitment of the inhibitory phosphatase, SHP-2.
30 PD-1-deficient B cells display enhanced proliferation in response to BCR cross linking and pd1 À/À mice are prone to the development of distinct autoimmune disorders, that is, lupus-like glomerulonephritis in the C57BL/6 background and cardiomyopathy in BALB-c pd1 ). Further complications are that the level of PD-1 expression is dependent on the degree of antigen stimulation and that its effectiveness is determined by the level of CD28-derived costimulatory signals. 34, 35 Overall, however, given the broad expression of B7-H1 in the periphery, it seems clear that PD-1 will influence the magnitude of local immune responses. Furthermore, it is likely that the response will depend on the scale of the antigenic challenge, and that exposure to grass pollens in the upper airway presents a higher-than-average burden of environmental antigens. It might also be relevant that PD-1 is expressed in the thymus and that in pd1 À/À mice positive selection is altered, 36 suggesting that PD-1 might influence the TCR repertoire and, in this way, indirectly affect the specificity of the response. The association between PD-1 and specific IgE responses is of clinical relevance as atopic individuals differ with regard to the allergens to which they react, which in turn determines their disease outcome. Allergy to house-dust mite and mould is associated with the development of asthma and bronchial hyper-responsiveness, whereas grass-pollen reactivity is linked with the less severe condition of allergic rhinitis. [37] [38] [39] Autoimmune diseases often cluster within families making it highly probable that they are controlled by overlapping sets of genetic factors. Moreover, it is not an uncommon finding that diseases with quite different phenotypes exhibit linkage or association with identical chromosomal regions or candidate genes. The CTLA4 region of chromosome 2, for example, confers susceptibility to Type I diabetes, Graves' disease and autoimmune hypothyroidism. 40 We have shown here that two of the PDCD1 SNPs influencing IgE responses also confer susceptibility to RA. Prokunina et al 41 and Lin et al 42 have also very recently reported associations of distinct single PDCD1 SNPs with RA in studies of relatively small cohorts (PD-1 þ 7078 and PD-1 þ 7717,  respectively) . The significance of these observations is questionable, however, given that, for the Taiwanese cases studied by Lin et al, the locus did not exhibit Hardy-Weinberg equilibrium, and that the association reported by Prokunina et al was relatively weak (P ¼ 0.053). The strong association of PDCD1 polymorphisms with atopy and RA that we observe, along with the earlier work of Prokunina et al, 14 which identified SNPs associated with SLE, indicate that the PDCD1 gene is indeed an important susceptibility locus for inherited inflammatory disease.
The SNPs we identified are intronic or synonymous, and we have yet to determine how they confer susceptibility to atopy or to RA. Overall, coding-region mutations conferring susceptibility to complex diseases seem to be relatively rare. Prokunina et al 14 showed that the PD-1 þ 7078 SNP alters a binding site for the RUNTrelated transcription factor-1 (RUNX1) located in an intronic enhancer. The direct involvement of this SNP in SLE has since been questioned by Ferreiros-Vidal et al, 43 although variation in haplotype structures identified in the two studies could account for the observed differences. Bioinformatic analysis of the regions of the novel SNPs we have identified failed to reveal any strong candidates for transcription factor binding sites (data not shown). The indications are, however, that we have much to learn about the complex functions of non-coding regions of the genome. 44 A striking feature of the organisation of the immune system is the relatively large number of molecules with classical and non-classical inhibitory signalling motifs, including CTLA-4 and PD-1, on the one hand, 45 and its active dependence on limited self-reactivity as a source of survival signals on the other (reviewed in Freitas and Rocha 46 ). The need to sustain overall responsiveness while constraining autoreactivity may favour a degree of redundancy among the large number of inhibitory molecules that allows the accumulation of alleles that only weakly compromise the functions of individual inhibitory proteins. Variation within the smaller set of genes encoding activating proteins might be less well tolerated by the immune system. These considerations suggest that the genes encoding other inhibitory proteins are worth investigating as potential susceptibility factors for inflammatory disease.
Materials and methods
Polymorphism detection
SNPs within the PDCD1 gene were detected by examination of the public databases and by sequencing five unrelated Caucasian individuals and a pool of 32 unrelated Caucasian individuals. This gave us a 99% probability of detecting alleles with a minimal frequency of 0.2. 47 Genomic regions of interest were amplified using appropriate primers (Table A Supplementary Information) . Products were purified and sequencing reactions performed using standard Big Dye protocols. Sequences were analysed for variants using PhredPhrap (http:// www.phrap.org). The exons, introns and the promoter of PDCD1 (accession number AF363458) were all screened.
Subjects
Two panels of subjects were studied for the association analysis of PDCD1 with atopy. The primary panel (Panel A) consisted of 364 subjects in 80 nuclear families sub selected to be discordant for atopy from a population sample of 230 families from Busselton in Western Australia. Positive associations were tested for replication in a second panel of subjects (Panel B) consisting of 410 white British individuals from 66 nuclear and five extended pedigrees, ascertained through members with asthma or rhinitis.
A case-control study was used to investigate the association of PDCD1 SNPs with RA. A total of 216 RA cases and 376 healthy controls were studied. The effects of population stratification were not controlled for beyond matching the patients and controls for age, sex and ethnicity. All of the subjects were British Caucasians from the Southwest of England. Controls were recruited from the Welsh Transplantation Board. All cases fulfilled the 1987 ACR criteria for RA 23 and were recruited from the rheumatology outpatient department of a tertiary referral centre.
Phenotyping of atopy Panels A and B
The same protocols were used to test both panels of families. Prick Skin Tests to HDM (Dermatophagoides pteronyssinus) and mixed grass pollen (less the response of negative controls), specific IgE titres to HDM and Timothy Grass (Phleum pratense) and the total serum IgE were measured as described previously. 48, 49 A 'Prick Skin Test Index (PSTI)' was calculated as the sum of the prick skin test results to HDM and grass mix (95% of individuals who were atopic reacted either to HDM, or to grass pollen or both). The RASTI was defined as the sum of the RAST scores for the serum IgE concentration specific to the same two allergens. Atopy was defined as a PSTI 45 mm, or a RASTI 42 or a total serum IgE 4the 7th decile of the age-corrected population. 'Normal' was defined as a PSTI of 0 and a RASTI of 0, and a total serum IgE othe 7th decile of the age-and sex-matched population. Asthma was defined as a positive answer to the questions 'Have you ever had an attack of asthma?' and 'If yes, has this happened on more than one occasion?' Genotyping SNPs were typed either by restriction digestion of PCR products or by MALDI TOF mass spectrometry (Sequenom Inc). For some SNPs genotyped by restriction digestion, restriction sites were engineered using mismatch primers using the 'Insizer' software (http:// zeon.well.ox.ac.uk/git-bin/insizer). Digestions were performed using between 3 and 5 ml of PCR product in a final volume of 10 ml with varying (SNP-dependent) quantities of enzyme according to the manufacturer's instructions. Digested products were resolved on either 2 or 4% agarose gels stained with ethidium bromide. Genotypes were confirmed independently by two individuals blind to the phenotype. Detailed PCR and RFLP conditions are given in Table B of the Supplementary Information. A total of 14 SNPs were genotyped using the MALDI TOF mass spectrometry system following the manufacturer's guidelines (Sequenom Inc.). In brief, multiplex PCR assays for the SNPs to be genotyped were designed using the MassARRAY assay design software. Genomic DNA was first taken through a primer extension preamplification (PEP) step 50 prior to being diluted 1 in 20 with sterile distilled water. Diluted PEP (2 ml) was used for each multiplex PCR. After PCR, primer extension was carried out using sequence-specific MassEXTEND primers and then mass spectrometry performed. Genotypes were called in real time by the Spectro-TYPER RT software. Details of the multiplex assays including PCR primers, PCR product lengths, MassExtend primers, termination mix (3 ddNTPs) and extension product sizes are given in Table C of the Supplementary Information.
Statistical analysis
All genotypes were subject to error checking including Mendelian inheritance testing using the Merlin programme. 51 Errors or inconsistencies were removed before statistical analysis. Transmission tests of association with the quantitative traits were performed in a variance components framework using the QTDT programme including age and sex as covariates. 52 The use of the orthogonal test for association allowed the use of multiple individuals within each family. For categorical trait association, analysis was carried out using the Monk's test routine of QTDT in family samples. 52, 53 Multiple comparisons were controlled by a simple Bonferroni correction.
To establish whether SNPs showing association were independent of one another, a stepwise procedure was performed in which the most significantly associated SNP was included as a covariate in the QTDT analysis. The analysis was then repeated, with the next most significantly associated remaining SNP included as an additional covariate, until no significant associations (Po0.01) remained. Haplotypes were derived from the pedigree data by the Merlin programme, 51 recoded as individual alleles and then tested for association by transmission tests.
For the RA case-control study, logistic regression analyses were performed with the presence or absence of RA as the dependent variable and genotypes for the various SNPs as the independent variables. The RA status was coded as 0 for absent or 1 for present and genotypes were coded as 0 for allele one homozygotes, 1 for heterozygotes and 2 for allele two homozygotes. Statistical analysis was carried out using the SPSS package (version 6.1).
